CHESTERFIELD, Mo., Oct. 29 /PRNewswire-FirstCall/ -- Reliv International, Inc. (Nasdaq: RELV), a nutrition and direct sellingcompany, today reported third-quarter net sales of $20.9 million vs. $23.9 million in the same quarter of 2008.
Net income was $324,000 vs. $536,000
In the United States, net sales totaled $18.3 million compared to $20.8 million in the third quarter of 2008. Net sales outside of the U.S. declined by approximately 14 percent. Excluding the impact of foreign currency fluctuations, however, the decline in foreign sales was about 5 percent.
Reliv also announced that it is reducing its dividend from $0.05 per share to $0.02 per share. For 2009, Reliv's annual dividend will be $0.07 rather than $0.10 per share.
"Despite the decline in our performance compared to last year's third quarter, we saw glimmers of light that we hope will shine brighter as we move into 2010," said Robert L. Montgomery, chairman, president and chief executive officer. "We achieved a five percent increase in the number of new distributors along with an increase in the number of orders this quarter over the third quarter of 2008," he said.
"This year we also reported a sequential increase in net sales from the second quarter to the third quarter for the first time since 2006," Montgomery said. "In addition, the number of orders and the size of the average order are up sequentially."
"The highlight of the third quarter was our international conference in St. Louis, where we introduced a new line of products under the Relivables name as well as a number of new business tools for distributors. All have been well received," Montgomery said.
For the first nine months of 2009, net sales totaled $64.7 million, down about 15 percent compared to the same period last year. U.S. sales decreased approximately 13 percent, while sales outside of the U.S. were down about 27 percent. Excluding foreign currency fluctuations, foreign sales were down 13.5 percent.
Net income for the first three quarters of this year equaled $1.7 million compared to $2.6 million for the first three quarters of 2008. Diluted earnings per share for the period equaled $0.13, down from diluted earnings per share of $0.17 for the first nine months of last year.
Reliv generated cash from operating activities of $4.8 million during the first nine months of 2009, an increase of approximately 34 percent over cash generated from operations during the same period last year. Reducing inventory levels was a key factor in the increase.
"In the fourth quarter, we are continuing a series of special events called the Financial Freedom Tour, launched earlier this year, in which we highlight the Reliv business opportunity. We expect to share the opportunity with a couple of thousand existing and potential distributors between October and November through these events," Montgomery said.
Commenting on the reduction in Reliv's dividend, Steven D. Albright, senior vice president and chief financial officer, said, "This is a difficult decision but we're confident it's the right one for Reliv. With profits down, we can invest the cost savings from the dividend to strengthen our business overall."
The dividend will be paid to all shareholders of record as of Nov. 9, 2009, to be paid on or about Nov. 19, 2009.
Reliv will host a conference call to discuss third-quarter earnings with investors. The conference call will be on October 29, 2009 at 1:00 p.m. Eastern. The dial-in number is 866-272-9941. The participant passcode is 10757749. A replay will be available for one week at 888-286-8010 using the passcode 37679647. A live webcast is available on the Investor Relations section of Reliv's Web site at: http://www.reliv.com/US/EN/Conference%20Calls%20Presentations.html
An online archive of the webcast will be on Reliv's Web site in the Investor Relations section, 24 hours after call concludes.
Reliv International, Inc., based in Chesterfield, Mo., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements. Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women's health and anti-aging. Reliv sells its products through an international network marketing system of approximately 68,000 independent distributors. Additional information about Reliv International, Inc. can be obtained on the Web at www.reliv.com.
The following table sets forth, as of September 30, 2009 and 2008, the number of our active distributors and Master Affiliates and above. The total number of active distributors includes Master Affiliates and above. We define an active distributor as one that enrolls as a distributor or renews its distributorship during the prior twelve months. Master Affiliates and above are distributors that have attained the highest level of discount and are eligible for royalties generated by Master Affiliates and above in their downline organization. Growth in the number of active distributors and Master Affiliates and above is a key factor in the growth of our business.
SOURCE Reliv International, Inc.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All